Timothy B Durham

Years Active: 2017-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy B Durham, Junliang Hao, Patrick Spinazze, Douglas R Stack, James L Toth, Steven Massey, Curren T Mbofana, Richard D Johnston, Jayana P Lineswala, Aaron Wrobleski, Jose Miguel Mínguez, Carlos Perez, Daryl L Smith, Jason Lamar, Rebecca Leon, Christopher Corkins, Jim D Durbin, Frances Tung, Sherry Guo, Ryan J Linder, Nathan Yumibe, Wei Wang, James MacKrell, Meghan Antonellis, Bethany Mascaro
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor. Journal of medicinal chemistry (2023)
Timothy B Durham, Jothirajah Marimuthu, James L Toth, Chin Liu, Lisa Adams, Daniel R Mudra, Craig Swearingen, Chaohua Lin, Mark G Chambers, Kannan Thirunavukkarasu, Michael R Wiley
A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose. Journal of medicinal chemistry 60 (13) (2017)
Edith Nagy, Ying Liu, Kacey J Prentice, Kyle W Sloop, Phillip E Sanders, Battsetseg Batchuluun, Craig D Hammond, Michael B Wheeler, Timothy B Durham
Synthesis and Characterization of Urofuranoic Acids: In Vivo Metabolism of 2-(2-Carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic Acid (CMPF) and Effects on in Vitro Insulin Secretion. Journal of medicinal chemistry 60 (5) (2017)

Timothy B Durham.css-eqlu8i{font-size:small;padding-left:4px;}